Fundamental analysis by Meta_Technical about Stock دتوزیع on 5/6/2020

Re -certification of two pharmaceutical products in Uzbekistan 5. The Uzbek Ministry of Health issued a re -registration certificate for two products of the Terptyleine Tablet Tablet Tablet Tablet. #Medicine This drug, which is used to treat depression, neurogenetic pain and migraine prophylacticism, is one of the most widely used products of the Darwakhsh factories that has been able to obtain export markets across the region in addition to the domestic market. Uzbekistan is one of the buyers of this pharmaceutical product, which has been registered in the country since year 2 and has been re -registered every five years. 🔹 In year 2, 5 mg packs were exported to Uzbekistan; But in 2008, due to export restrictions and the lack of licenses by the government, this product was not issued. Experts in the export sector of the pharmaceutical and company agency in Uzbekistan predict that if they are licensed, there will be 6,000 mg AmiPteiline packages and 6,000 packets of 1mm Amiotylp in the first six months of this year to Central Asia. It is noteworthy that in the last three years, due to the intensification of sanctions against Iran, the government's policy has been aimed at restricting the export of the pharmaceutical sector and prioritizing the domestic need, which has had a negative impact on the export markets of the country's pharmaceutical industry and is expected to take the necessary measures to maintain domestic export markets. @meta_technical